2012-002199-15
A Phase III double-blind, randomised, placebo controlled trial of long term therapy on Exacerbation Rate in patients with stable COPD using Doxycycline
Imperial College London·EU Clinical Trials RegisterCompleted
Study focus
- Disease/Condition
- COPD Chronic Obstructive Pulmonary Disease
Sponsor & location
- Primary sponsor
- Imperial College London
- Funder
- National Institute for Health Research
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Other chronic obstructive pulmonary diseaseOther specified chronic obstructive pulmonary diseaseChronic obstructive pulmonary disease, unspecifiedChronic obstructive pulmonary disease with acute exacerbation, unspecifiedChronic obstructive pulmonary disease with acute lower respiratory infection
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2012-002199-15
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2012-002199-15 through Pure Global AI's free database. This phase not specified trial is sponsored by Imperial College London and is currently Completed. The study focuses on COPD Chronic Obstructive Pulmonary Disease.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.